About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Faculty & Staff
The highly productive, specialized researchers within the Weill Cornell Department of Genetic Medicine are leaders in their respective fields. Our gene therapy and stem cell researchers have carried out human trials for cystic fibrosis, cardiac ischemia, cancer and central nervous system disorders, and were the first to use a recombinant virus as a vehicle for in vivo gene therapy. In addition, our personalized medicine researchers utilize state-of-the-art microarray technology for genome-wide characterization of gene expression, single nucleotide polymorphism and copy number variation, conducting cutting-edge studies to identify candidate genes associated with complex conditions including chronic obstructive pulmonary disease.
Letter from our Chair
The Weill Cornell Department of Genetic Medicine is a translational research program focused on genetic therapies and personalized medicine. Personalized medicine is the use of information and data from an individual's genotype or level of gene expression to stratify complex diseases, select medications and dosages, provide therapy, and initiate preventative measures specifically suited to a patient. In addition to genetic information, other factors including imaging, laboratory and clinical information about a disease process and/or patient are integrated into the process of developing personalized medicine. Our research program operates in close collaboration with other Weill Cornell Medicine laboratories, as well as laboratory programs of affiliated institutions, including Malcolm Moore's stem cell group at Memorial Sloan Kettering Cancer Center (MSKCC). Of particular note are our personalized medicine projects with colleagues at Weill Cornell Medical College-Qatar and Hamad Medical Corporation, and our bioinformatics collaborations with Cornell-Ithaca researchers, including Andy Clark and Jason Mezey.